Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Eger – page 5

247 clinical trials in Eger, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Eger at a glance
247
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

247 trials in Eger

Open in trial search

A Study of Amivantamab With Carboplatin and Pembrolizumab for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Amivantamab
  • Sponsor:Janssen - Cilag International

Schizophrenia

Recruiting

Long-Term Safety Study of Direclidine in Adults with Schizophrenia

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Direclidine
  • Sponsor:Neurocrine Biosciences Inc.

A Study of MK-1084 and Drug Combination Versus Pembrolizumab and Chemotherapy for Adults with Advanced Lung Cancer with KRAS G12C Mutation

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC

Schizophrenia

Recruiting

A study testing direclidine compared to placebo in adults with schizophrenia who need hospital care

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Direclidine
  • Sponsor:Neurocrine Biosciences Inc.

A Study of fesoterodine and 5-[(1R,5R)-3-Azabicyclo[3.

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Betovumeline
  • Sponsor:Maplight Therapeutics Inc.

Study of divarasib and pembrolizumab compared to standard chemotherapy in previously untreated KRAS G12C-mutated advanced non-small cell lung cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:F. Hoffmann-La Roche AG

Study comparing GSK5764227 and topotecan in adults with relapsed small cell lung cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:GSK5764227
  • Sponsor:Glaxosmithkline Research & Development Limited

Study of sacituzumab tirumotecan, pembrolizumab and chemotherapy combination for early-stage triple-negative breast cancer or hormone receptor-low positive/HER2-negative breast cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Merck Sharp & Dohme LLC

Study of THIO and cemiplimab compared to chemotherapy in patients with advanced non-small cell lung cancer who have received two previous treatments

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Maia Biotechnology Inc.

Safety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Osavampator
  • Sponsor:Neurocrine Biosciences Inc.

Study of efgartigimod given by IV infusion in adolescents aged 12-17 years with chronic immune thrombocytopenia

Investigational
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Evaluating NBI-1065845 as an Additional Treatment for Adults with Major Depressive Disorder Who Are Not Responding Adequately to Current Therapy

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Osavampator
  • Sponsor:Neurocrine Biosciences Inc.

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Eger

What the registry says about research in the country

01 Oncology Research

Advanced clinical trials focusing on bladder cancer treatments and innovative therapies for metastatic breast cancer. Studies evaluate new combination treatments and their effectiveness in improving patient outcomes.

  • Bladder Cancer Immunotherapy
  • Metastatic Breast Cancer Treatment
  • Colorectal Cancer Therapies

Multiple trials investigating targeted treatments for various stages of cancer, including new approaches for KRAS/NRAS mutations.

02 Hematological Disorders

Comprehensive research into blood-related conditions, including B-cell malignancies and various forms of leukemia. Studies focus on novel therapeutic approaches and combination treatments.

  • Chronic Lymphocytic Leukemia
  • Diffuse Large B-cell Lymphoma
  • Myelodysplastic Syndrome

Innovative treatments being evaluated for both newly diagnosed and relapsed/refractory conditions.

03 Chronic Conditions

Studies addressing various chronic conditions, including osteoarthritis and autoimmune disorders. Research focuses on pain management and improving patient mobility.

  • Knee Osteoarthritis Treatment
  • Rheumatoid Arthritis Management
  • Sjögren's Syndrome Therapy

Evaluating both conventional and innovative treatment approaches for chronic inflammatory conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.